A Randomized, Placebo-controlled, Double-blind Phase II Study to Evaluate the Efficacy of IZN-6D4 Gel for the Treatment of Diabetic Foot Ulcers
Phase of Trial: Phase II
Latest Information Update: 07 Jan 2016
At a glance
- Drugs IZN 6D4 (Primary)
- Indications Diabetic foot ulcer
- Focus Therapeutic Use
- Sponsors Izun Pharma
- 05 Jan 2016 According to an Izun Pharmaceuticals media release, the results of this study will be presented at the Biotech Showcase, in January 2016.
- 13 Oct 2015 Results published in an Izun Pharmaceuticals media release.
- 13 Oct 2015 Status changed from recruiting to completed according to an Izun Pharmaceuticals media release.